Article Details

HC Wainwright Analysts Give Sorrento Therapeutics (NASDAQ:SRNE) a $40.00 Price Target

Retrieved on: 2018-05-13 21:07:30

Tags for this article:

Click the tags to see associated articles and topics

HC Wainwright Analysts Give Sorrento Therapeutics (NASDAQ:SRNE) a $40.00 Price Target. View article details on hiswai:

Excerpt

<div>Finally, <b>Acadian Asset Management</b> LLC bought a new position in Sorrento Therapeutics in the 4th quarter valued at approximately $200,000. 12.19% ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo